CoMFA and CoMSIA studies of angiotensin (AT1) receptor antagonists

被引:16
作者
Datar, P [1 ]
Desai, P [1 ]
Coutinho, E [1 ]
Iyer, K [1 ]
机构
[1] Bombay Coll Pharm, Dept Pharmaceut Chem, Santacruz E 400098, Mumbai, India
关键词
AT1 receptor antagonists; CoMFA; CoMSIA; consensus dynamics;
D O I
10.1007/s00894-002-0097-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two 3D-QSAR methods - CoMFA and CoM-SIA - were applied to a set of 38 angiotensin receptor (AT1) antagonists. The conformation and alignment of molecules were obtained by a novel method - consensus dynamics. The representation of biological activity, partial charge formalism, absolute orientation of the molecules in the grid, and grid spacing were also studied for their effect on the CoMFA models. The models were thoroughly validated through trials using scrambled activities and bootstrapping. The best CoMFA model had a cross-validated correlation coefficient (q(2)) of 0.632, which improved with "region focusing" to 0.680. This model had a "predictive" r(2) of 0.436 on a test series that was unique and with little representation in the training set. Although the "predictive" r(2) of the best CoMSIA model, which included steric, electrostatic, and hydrogen bond acceptor fields was higher than that of the best CoMFA model, the other statistical parameters like q(2), r(2), F value, and s were unsatisfactory. The contour maps generated using the best CoMFA model were used to identify the structural features important for biological activity in these compounds.
引用
收藏
页码:290 / 301
页数:12
相关论文
共 54 条
[1]   QUINAZOLINONES-1 - DESIGN AND SYNTHESIS OF POTENT QUINAZOLINONE-CONTAINING AT(1)-SELECTIVE ANGIOTENSIN-II RECEPTOR ANTAGONISTS [J].
ALLEN, EE ;
DELASZLO, SE ;
HUANG, SX ;
QUAGLIATO, CS ;
GREENLEE, WJ ;
CHANG, RSL ;
CHEN, TB ;
FAUST, KA ;
LOTTI, VJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (06) :1293-1298
[2]  
ALLEN EE, 1991, 202 NAT M AM CHEM SO
[3]   PHILADELPHIA CHROMOSOME-POSITIVE LEUKEMIA - THE TRANSLOCATED GENES AND THEIR GENE-PRODUCTS [J].
ALLEN, PB ;
MORGAN, GJ ;
WIEDEMANN, LM .
BAILLIERES CLINICAL HAEMATOLOGY, 1992, 5 (04) :897-930
[4]  
BAGLEY S, 1992, Patent No. 5175164
[5]   A 3D QSAR CoMFA study of non-peptide angiotensin II receptor antagonists [J].
Belvisi, L ;
Bravi, G ;
Catalano, G ;
Mabilia, M ;
Salimbeni, A ;
Scolastico, C .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1996, 10 (06) :567-582
[6]   A 3D QSAR APPROACH TO THE SEARCH FOR GEOMETRICAL SIMILARITY IN A SERIES OF NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS [J].
BELVISI, L ;
BRAVI, G ;
SCOLASTICO, C ;
VULPETTI, A ;
SALIMBENI, A ;
TODESCHINI, R .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1994, 8 (02) :211-220
[7]   MOLECULAR-DYNAMICS WITH COUPLING TO AN EXTERNAL BATH [J].
BERENDSEN, HJC ;
POSTMA, JPM ;
VANGUNSTEREN, WF ;
DINOLA, A ;
HAAK, JR .
JOURNAL OF CHEMICAL PHYSICS, 1984, 81 (08) :3684-3690
[8]   Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa [J].
Böhm, M ;
Stürzebecher, J ;
Klebe, G .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (03) :458-477
[9]   SAMPLE-DISTANCE PARTIAL LEAST-SQUARES - PLS OPTIMIZED FOR MANY VARIABLES, WITH APPLICATION TO COMFA [J].
BUSH, BL ;
NACHBAR, RB .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1993, 7 (05) :587-619
[10]   A HIGHLY POTENT, ORALLY-ACTIVE IMIDAZO[4,5-B]PYRIDINE BIPHENYLACYLSULFONAMIDE (MK-996-L-159,282) - A NEW ANGIOTENSIN-II RECEPTOR ANTAGONIST [J].
CHAKRAVARTY, PK ;
NAYLOR, EM ;
CHEN, A ;
CHANG, RSL ;
CHEN, TB ;
FAUST, KA ;
LOTTI, VJ ;
KIVLIGHN, SD ;
GABLE, RA ;
ZINGARO, GJ ;
SCHORN, TW ;
SCHAFFER, LW ;
BROTEN, TP ;
SIEGL, PKS ;
PATCHETT, AA ;
GREENLEE, WJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (24) :4068-4072